MLICM
NRC icon

Metropolitan Life Insurance Company (MetLife)’s NRC Health Common Stock NRC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-756
Closed -$29.9K – 1395
2024
Q1 		$29.9K Sell
756
-167
-18% -$6.61K ﹤0.01% 1664
2023
Q4 		$36.5K Hold
923
– – ﹤0.01% 1610
2023
Q3 		$41K Buy
923
+162
+21% +$7.07K ﹤0.01% 1518
2023
Q2 		$33.1K Hold
761
– – ﹤0.01% 1661
2023
Q1 		$33.1K Sell
761
-155
-17% -$6.84K ﹤0.01% 1616
2022
Q4 		$34.2K Hold
916
– – ﹤0.01% 1706
2022
Q3 		$36.5K Hold
916
– – ﹤0.01% 1679
2022
Q2 		$35.1K Hold
916
– – ﹤0.01% 1718
2022
Q1 		$36.3K Sell
916
-3,250
-78% -$127K ﹤0.01% 1769
2021
Q4 		$173K Hold
4,166
– – ﹤0.01% 2124
2021
Q3 		$176K Buy
4,166
+75
+2% +$3.78K ﹤0.01% 2178
2021
Q2 		$188K Hold
4,091
– – ﹤0.01% 2191
2021
Q1 		$192K Hold
4,091
– – ﹤0.01% 2047
2020
Q4 		$175K Hold
4,091
– – ﹤0.01% 2021
2020
Q3 		$201K Hold
4,091
– – ﹤0.01% 1770
2020
Q2 		$238K Hold
4,091
– – ﹤0.01% 1687
2020
Q1 		$186K Sell
4,091
-75
-2% -$4.5K ﹤0.01% 1629
2019
Q4 		$275K Hold
4,166
– – ﹤0.01% 1701
2019
Q3 		$241K Buy
4,166
+655
+19% +$40.6K ﹤0.01% 1752
2019
Q2 		$202K Hold
3,511
– – ﹤0.01% 1885
2019
Q1 		$136K Hold
3,511
– – ﹤0.01% 2139
2018
Q4 		$134K Hold
3,511
– – ﹤0.01% 2088
2018
Q3 		$136K Hold
3,511
– – ﹤0.01% 2266
2018
Q2 		$131K Hold
3,511
– – ﹤0.01% 2184
2018
Q1 		$103K Hold
3,511
– – ﹤0.01% 2281
2017
Q4 		$131K Sell
3,511
-3,667
-51% -$130K ﹤0.01% 2157
2017
Q3 		$271K Hold
7,178
– – ﹤0.01% 2095
2017
Q2 		$193K Buy
+7,178
New +$175K ﹤0.01% 2354
2013
Q4 		– Sell
-8,794
Closed -$166K – 2753
2013
Q3 		$166K Sell
8,794
-7,148
-45% -$123K ﹤0.01% 2556
2013
Q2 		$287K Buy
+15,942
New +$255K ﹤0.01% 2081

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NRC Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of NRC Health Common Stock (NRC) in Q2 2024, closing a stake of 756 shares — an estimated $29.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NRC in Q2 2013 and held it in 30 quarters. The position peaked at $287K in Q2 2013. 136 funds tracked by Wall St. Rank hold NRC as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining NRC Health Common Stock position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 756 NRC Health Common Stock shares in Q2 2024, an estimated $29.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in NRC Health Common Stock in Q2 2013 and held it in 30 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s NRC Health Common Stock position peaked at $287K in Q2 2013.
  • 136 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.